SCHEMBL30740799

SCHEMBL30740799

COC(=O)c1ccnc(Oc2ccc(C)cc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
NPC1 O15118 2/20 0.49
P2RX3 P56373 3/20 0.47
CYP2C9 P11712 2/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 3/20 0.45
TDP1 Q9NUW8 1/20 0.42
PDGFRA P16234 1/20 0.42
KDR P35968 1/20 0.42
GAA P10253 2/20 0.40
GALR3 O60755 1/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALOX5AP P20292 1/20 0.40
FEN1 P39748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24512733 0.87 MAPT (0.47) RAB9ASMN1; SMN2P2RX3CYP2C9CYP1A2
SCHEMBL4859054 0.87 TDP1 (0.51) RAB9ASMN1; SMN2P2RX3CYP1A2ALDH1A1
SCHEMBL17591033 0.85 P2RX3 (0.55) RAB9ASMN1; SMN2NPC1P2RX3CYP2C9
SCHEMBL29826782 0.85 P2RX3 (0.55) RAB9ASMN1; SMN2NPC1P2RX3CYP2C9
SCHEMBL22518516 0.79 MAPK1 (0.44) RAB9ASMN1; SMN2NPC1CYP2C9TP53
SCHEMBL6014711 0.78 KDR (0.49) P2RX3ALDH1A1PDGFRAKDRGALR3
SCHEMBL24124575 0.75 TDP1 (0.67) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL24920948 0.74 ACACB (0.42) RAB9ASMN1; SMN2NPC1P2RX3ALDH1A1
SCHEMBL4384494 0.74 MAPK1 (0.46) RAB9ASMN1; SMN2NPC1CYP2C9TP53
SCHEMBL22676056 0.74 SCN9A (0.45) RAB9ASMN1; SMN2NPC1CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117043154-A GPCR receptor agonists, pharmaceutical compositions comprising same, and methods of use thereof 卡莫特医疗有限公司 2023-11-10 CN disclosed